LFVN – lifevantage corporation (US:NASDAQ)

News

Lifevantage (NASDAQ:LFVN) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health [Yahoo! Finance]
New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health
Are Investors Undervaluing Lifevantage (LFVN) Right Now? [Yahoo! Finance]
Lifevantage (NASDAQ:LFVN) was upgraded by analysts at Lake Street Capital to a "strong-buy" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com